Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation
Completed · Phase 3
Conditions studied: Persistent Atrial Fibrillation
In brief
The purpose of this prospective randomized study is to assess whether empirical Left Atrial Appendage (LAA) isolation along with the standard approach of pulmonary vein isolation (PVI) and ablation of extra-pulmonary triggers is superior to the standard approach alone in enhancing the long-term success rate of catheter ablation in persistent or long-standing persistent atrial fibrillation (AF) patients.
Key facts
- Study ID
- NCT01362738
- Run by
- Texas Cardiac Arrhythmia Research Foundation
- People needed
- 156
- Starts
- 2010-11-01
- Expected to finish
- 2016-11-01
- Last updated by the study team
- 2017-04-26
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 18-75 years
- History of PeAF or LSP AF refractory to antiarrhythmic drugs
- Willing and ability to understand and sign an informed consent
You may not qualify if…
- Reversible causes of AF (hyperthyroidism)
- Left atrial thrombus
- Moderate to severe valvular heart disease
- Contraindication for anticoagulation
- Life expectancy < 12 months
- Pregnancy
Where it is running
- St. David's Medical Center — Austin, Texas, United States
- Texas Cardiac Arrhythmia Research Foundation — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.